Plain-English translation of NCT05387304 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Ruijin Hospital are following up to 250,000 people in Shanghai who have tested positive for COVID-19 to learn more about how the infection affects them long-term. The study includes both people who had no symptoms and those who were sick, and it will track changes in heart and lung function, organ health, and mental well-being over time.
We still don't fully understand how COVID-19 affects people's health weeks, months, and years after infection — especially with newer virus variants. This study will help doctors identify who is most at risk for long-term problems and what those problems might be.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be part of a long-term tracking study where researchers check in on your health periodically over time. This likely involves health visits where doctors may test your heart and lung function, ask about your symptoms, and measure how the infection has affected you — but the exact schedule and specific tests will be explained when you enroll.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China
~250,000 participants
Started
March 2022
Primary completion
May 2032
Last updated on clinicaltrials.gov in May 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ying Chen, Ph D
Ruijin Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.